Renaissance Technologies LLC Invests $3.37 Million in National Health Investors, Inc. $NHI

Key Points

• Renaissance Technologies opened a new National Health Investors position worth approximately $3.37 million, purchasing 41,699 shares and acquiring about 0.09% of the healthcare REIT.
• Institutional investors own 62.51% of NHI, while CEO D. Eric Mendelsohn and Director Robert A. McCabe Jr. recently bought shares, increasing insider ownership to 2.70%.
• Analyst sentiment remains a “Moderate Buy”, with five Buy, two Hold and one Sell rating and an average price target of $83.86 versus the stock’s $75.40 opening price.

Renaissance Technologies LLC bought a new position in National Health Investors, Inc. (NYSE:NHI - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 41,699 shares of the real estate investment trust's stock, valued at approximately $3,372,000. Renaissance Technologies LLC owned approximately 0.09% of National Health Investors at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Principal Financial Group Inc. grew its holdings in shares of National Health Investors by 1.9% in the fourth quarter. Principal Financial Group Inc. now owns 1,668,006 shares of the real estate investment trust's stock valued at $127,386,000 after purchasing an additional 30,968 shares in the last quarter. Forty three Eighteen Advisors LLC purchased a new stake in shares of National Health Investors during the 1st quarter valued at about $2,005,000. Legal & General Group Plc lifted its holdings in shares of National Health Investors by 22.8% in the 4th quarter. Legal & General Group Plc now owns 251,588 shares of the real estate investment trust's stock valued at $19,214,000 after acquiring an additional 46,715 shares during the last quarter. M&T Bank Corp bought a new position in shares of National Health Investors in the 4th quarter valued at about $2,996,000. Finally, Morgan Stanley Institutional Investment Advisors LLC purchased a new position in National Health Investors in the fourth quarter worth about $5,883,000. 62.51% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on NHI shares. Zacks Research cut National Health Investors from a "hold" rating to a "strong sell" rating in a report on Thursday, June 25th. Cantor Fitzgerald restated an "overweight" rating and set a $94.00 price target on shares of National Health Investors in a report on Wednesday, April 22nd. BMO Capital Markets dropped their price objective on shares of National Health Investors from $90.00 to $80.00 and set an "outperform" rating for the company in a research note on Monday, June 15th. Wells Fargo & Company reduced their target price on shares of National Health Investors from $84.00 to $79.00 and set an "equal weight" rating on the stock in a research note on Monday, June 1st. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on shares of National Health Investors from $85.00 to $80.00 and set a "hold" rating for the company in a research note on Thursday, June 25th. Five research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $83.86.

Insider Buying and Selling at National Health Investors

In other National Health Investors news, CEO D. Eric Mendelsohn acquired 1,500 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was bought at an average cost of $68.84 per share, with a total value of $103,260.00. Following the completion of the purchase, the chief executive officer directly owned 133,316 shares in the company, valued at $9,177,473.44. The trade was a 1.14% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert A. Mccabe, Jr. acquired 890 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was acquired at an average cost of $71.65 per share, with a total value of $63,768.50. Following the completion of the purchase, the director owned 44,159 shares of the company's stock, valued at $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 2.70% of the stock is currently owned by corporate insiders.

National Health Investors Stock Up 0.0%

NYSE:NHI opened at $75.40 on Friday. The company has a market cap of $3.65 billion, a price-to-earnings ratio of 24.32, a price-to-earnings-growth ratio of 3.38 and a beta of 0.51. National Health Investors, Inc. has a twelve month low of $67.94 and a twelve month high of $91.38. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. The stock has a fifty day simple moving average of $75.13 and a 200-day simple moving average of $79.61.

About National Health Investors

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source